Cinnamon & Type 2 Diabetes: Evidence, Dosing & Safety

Evidence Summary

  • Glycemic control: Meta-analyses (10–15 RCTs) show cinnamon 1–6 g/day reduces fasting glucose 10–25 mg/dL and HbA1c 0.3–0.5% vs. placebo in T2D.
  • Insulin sensitivity: Improves HOMA-IR in some trials; polyphenols (MHCP) enhance insulin signaling.
  • Lipids: Modest reductions in total cholesterol, LDL-C, triglycerides.
  • Antioxidant/anti-inflammatory: Cinnamaldehyde, polyphenols scavenge ROS, inhibit NF-κB.

Cinnamon Types Matter

  • Ceylon (C. verum): Low coumarin (<0.004%); preferred for daily use.
  • Cassia (C. cassia): High coumarin (1–5%); hepatotoxic risk at >1 tsp/day long-term.

Practical Recommendations

  1. Dose: 1–3 g/day (½–1 tsp) Ceylon cinnamon powder in food/beverage.
  2. Duration: Trial 3–6 months; monitor HbA1c, LFTs.
  3. Form: Powder > capsules (quality control); avoid essential oil internally.
  4. Contraindications: Liver disease, anticoagulants (potentiation), pregnancy (high dose).

Bottom Line

Cinnamon is a promising adjunct, not a replacement for guideline-directed therapy. Discuss with your diabetes team before starting.

Diabetes - Related Articles